Details for New Drug Application (NDA): 089166
✉ Email this page to a colleague
NDA 089166 describes SYNALGOS-DC-A, which is a drug marketed by Leitner Pharms and is included in one NDA. Additional details are available on the SYNALGOS-DC-A profile page.
The generic ingredient in SYNALGOS-DC-A is acetaminophen; caffeine; dihydrocodeine bitartrate. There are sixty-six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the acetaminophen; caffeine; dihydrocodeine bitartrate profile page.
The generic ingredient in SYNALGOS-DC-A is acetaminophen; caffeine; dihydrocodeine bitartrate. There are sixty-six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the acetaminophen; caffeine; dihydrocodeine bitartrate profile page.
Summary for 089166
| Tradename: | SYNALGOS-DC-A |
| Applicant: | Leitner Pharms |
| Ingredient: | acetaminophen; caffeine; dihydrocodeine bitartrate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 356.4MG;30MG;16MG | ||||
| Approval Date: | May 14, 1986 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
